David G. Wong
About
David G. Wong is a scholar working on Psychiatry and Mental health, Endocrinology, Diabetes and Metabolism and Clinical Psychology.
According to data from OpenAlex, David G. Wong has authored 24 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Psychiatry and Mental health, 14 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Clinical Psychology. Recurrent topics in David G. Wong's work include Sexual function and dysfunction studies (20 papers), Hormonal and reproductive studies (14 papers) and Sexuality, Behavior, and Technology (12 papers). David G. Wong is often cited by papers focused on Sexual function and dysfunction studies (20 papers), Hormonal and reproductive studies (14 papers) and Sexuality, Behavior, and Technology (12 papers). David G. Wong collaborates with scholars based in United States, France and Mexico. David G. Wong's co-authors include Claus G. Roehrborn, Haoyue Zeigler, Patrick R. Burns, Pierre Costa, Stephen M. Auerbach, R. Blair Egerdie, Roberta J. Secrest, Sanjeev Ahuja, Anne Esler and Fanni Natanegara and has published in prestigious journals such as The Journal of Urology, Urology and Journal of Hypertension.
In The Last Decade
David G. Wong
23 papers receiving 635 citations
Peers
David G. Wong
Adolfo Casabé Argentina
M.J. Mathers Germany
Sebastian Sorsaburu United States
Albert Elion‐Mboussa United States
Amr El-Meliegy United States
Ki Hak Moon South Korea
Lucio Varanese United Kingdom
Luigi Barbieri Italy
William P. Fitch United States
Keith Bangerter United States
Citations per year, relative to David G. Wong David G. Wong (= 1×)
peers
Adolfo Casabé
Countries citing papers authored by David G. Wong
Since
Specialization
Citations
This map shows the geographic impact of David G. Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Wong more than expected).
Fields of papers citing papers by David G. Wong
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by David G. Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Wong. The network helps show where David G. Wong may publish in the future.
Co-authorship network of co-authors of David G. Wong
This figure shows the co-authorship network connecting the top 25 collaborators of David G. Wong. A scholar is included among the top collaborators of David G. Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David G. Wong. David G. Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Zatzick, Douglas, et al.. (2025). A Pilot Randomized Clinical Trial of a Collaborative Care Intervention for Spanish-Speaking Injury Survivors. Psychiatry. 89(1). 29–43.
2.
Roehrborn, Claus G., Kathryn B. Egan, Martin Miner, et al.. (2016). Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia ( LUTS / BPH ) combined responders to tadalafil after 12 weeks of treatment. British Journal of Urology. 118(1). 153–160.
3.
Egan, Kathryn B., Arthur L. Burnett, Kevin T. McVary, et al.. (2015). The Co-occurring Syndrome—Coexisting Erectile Dysfunction and Benign Prostatic Hyperplasia and Their Clinical Correlates in Aging Men: Results From the National Health and Nutrition Examination Survey. Urology. 86(3). 570–580.
4.
Egan, Kathryn B., R. Rosen, Arthur L. Burnett, et al.. (2015). Rural vs. urban disparities in association with lower urinary tract symptoms and benign prostatic hyperplasia in ageing men, NHANES 2001-2008. International Journal of Clinical Practice. 69(11). 1316–1325.
5.
Schoenfeld, Michael J., et al.. (2013). Treatment Patterns in Alpha-Blocker Therapy for Benign Prostatic Hyperplasia. American Journal of Men s Health. 8(3). 267–272.
6.
Carson, C C, et al.. (2013). Tadalafil - a therapeutic option in the management of BPH-LUTS. International Journal of Clinical Practice. 68(1). 94–103.
7.
Brock, Gerald, Kevin T. McVary, Claus G. Roehrborn, et al.. (2013). Direct Effects of Tadalafil on Lower Urinary Tract Symptoms versus Indirect Effects Mediated through Erectile Dysfunction Symptom Improvement: Integrated Data Analyses from 4 Placebo Controlled Clinical Studies. The Journal of Urology. 191(2). 405–411.
8.
Egerdie, R. Blair, Stephen M. Auerbach, Claus G. Roehrborn, et al.. (2011). Tadalafil 2.5 or 5 mg Administered Once Daily for 12 Weeks in Men with Both Erectile Dysfunction and Signs and Symptoms of Benign Prostatic Hyperplasia: Results of a Randomized, Placebo-Controlled, Double-Blind Study. The Journal of Sexual Medicine. 9(1). 271–281.
9.
Porst, Hartmut, Sidney Glina, David Ralph, et al.. (2010). Durability of Response Following Cessation of Tadalafil Taken Once Daily as Treatment for Erectile Dysfunction. The Journal of Sexual Medicine. 7(10). 3487–3494.
10.
Althof, Stanley E., Eusebio Rubio‐Aurioles, Sheryl A. Kingsberg, et al.. (2010). Impact of Tadalafil Once Daily in Men With Erectile Dysfunction—Including a Report of the Partners' Evaluation. Urology. 75(6). 1358–1363.
11.
Shabsigh, Ridwan, Craig F. Donatucci, Raymond A. Costabile, et al.. (2009). Reliability of efficacy in men with erectile dysfunction treated with tadalafil once daily after initial success. International Journal of Impotence Research. 22(1). 1–8.
12.
Seftel, A D, Irène Buvat, Stanley E. Althof, et al.. (2009). Improvements in confidence, sexual relationship and satisfaction measures: results of a randomized trial of tadalafil 5 mg taken once daily. International Journal of Impotence Research. 21(4). 240–248.
13.
Shabsigh, Ridwan, Gregory A. Broderick, Stanley E. Althof, Fanni Natanegara, & David G. Wong. (2009). Daily patterns of sexual intercourse attempts by men with erectile dysfunction treated with tadalafil: influence of age and marital status. International Journal of Impotence Research. 21(5). 285–291.
14.
Rubio‐Aurioles, Eusebio, Edward D. Kim, Raymond C. Rosen, et al.. (2009). Impact on Erectile Function and Sexual Quality of Life of Couples: A Double-Blind, Randomized, Placebo-Controlled Trial of Tadalafil Taken Once Daily. The Journal of Sexual Medicine. 6(5). 1314–1323.
15.
Shabsigh, Ridwan, R. Rosen, Rajesh Shinghal, et al.. (2008). Response to treatment with tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline. International Journal of Impotence Research. 20(6). 554–560.
16.
Donatucci, Craig F., David G. Wong, François Giuliano, et al.. (2008). Efficacy and safety of tadalafil once daily: considerations for the practical application of a daily dosing option. Current Medical Research and Opinion. 24(12). 3383–3392.
17.
Sharlip, Ira D., Bryan P. Shumaker, Lukman Hakim, et al.. (2008). Tadalafil Is Efficacious and Well Tolerated in the Treatment of Erectile Dysfunction (ED) in Men over 65 Years of Age: Results from Multiple Observations in Men with ED in National Tadalafil Study in the United States. The Journal of Sexual Medicine. 5(3). 716–725.
18.
Goldstein, Irwin, Edward Kim, William D. Steers, et al.. (2007). Efficacy and Safety of Tadalafil in Men with Erectile Dysfunction with a High Prevalence of Comorbid Conditions: Results from MOMENTUS: Multiple Observations in Men with Erectile Dysfunction in National Tadalafil Study in the US. The Journal of Sexual Medicine. 4(1). 166–175.
19.
Morgentaler, Abraham, James H. Barada, Craig Niederberger, et al.. (2006). Efficacy and Safety of Tadalafil Across Ethnic Groups and Various Risk Factors in Men with Erectile Dysfunction: Use of a Novel Noninferiority Study Design. The Journal of Sexual Medicine. 3(3). 492–503.
20.
Spence, J. David, et al.. (1985). Blood Pressure Measurement in the Elderly: Correlation of Arterial Stiffness with Difference Between Intra-arterial and Cuff Pressures. Journal of Hypertension. 3(3). 231–235.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Adolfo Casabé Breakdown of academic impact, for papers by M.J. Mathers Breakdown of academic impact, for papers by Sebastian Sorsaburu Breakdown of academic impact, for papers by Albert Elion‐Mboussa Breakdown of academic impact, for papers by Amr El-Meliegy Breakdown of academic impact, for papers by Ki Hak Moon Breakdown of academic impact, for papers by Lucio Varanese Breakdown of academic impact, for papers by Luigi Barbieri Breakdown of academic impact, for papers by William P. Fitch Breakdown of academic impact, for papers by Keith Bangerter